Change - Announcement of Appointment::APPOINTMENT OF CHIEF FINANCIAL OFFICER OF HEALTH MANAGEMENT INTERNATIONAL LTD

Issuer & Securities

Issuer/ Manager
HEALTH MANAGEMENT INTERNATIONAL LTD
Securities
HEALTH MANAGEMENT INTL LTD - SG1H18874567 - 588
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
28-Feb-2019 18:11:04
Status
New
Announcement Sub Title
APPOINTMENT OF CHIEF FINANCIAL OFFICER OF HEALTH MANAGEMENT INTERNATIONAL LTD
Announcement Reference
SG190228OTHRQP28
Submitted By (Co./ Ind. Name)
Dr Gan See Khem
Designation
Executive Chairman and Managing Director
Description (Please provide a detailed description of the event in the box below)
Please see below.

Additional Details

Date Of Appointment
01/03/2019
Name Of Person
Yow Lee Chan
Age
63
Country Of Principal Residence
Malaysia
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Board of Directors of the Company has reviewed the Nominating Committee's recommendation and the qualification, experience and suitability of Ms Yow Lee Chan and accordingly, the Board has approved the appointment of Ms Yow Lee Chan as Chief Financial Officer of the Company.
Whether appointment is executive, and if so, the area of responsibility
The appointment is an executive position.

Ms Yow Lee Chan is responsible for overseeing the Group's financial reporting and governance matters as well as driving the improvement of the Group's overall financial performance.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Professional qualifications
Bachelor of Commerce and Administration, Victoria University, New Zealand
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
1 September 2017 - current date
Senior Advisor, Finance
Health Management International Ltd

January 2016 - September 2016
Head, Hong Kong Clinic Operations
Parkway Pantai Limited

2014 - 2015
Head, North Asia and SEA Operations
Parkway Pantai Limited

2012 - 2013
Consultant
InterMedika

1996 - 2011
Chief Financial Officer
Bumrungrad Hospital PCL
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Principal Commitments* Including Directorships#
*"Principal Commitments" has the same meaning as defined in the Code
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
M & P Investments Pte Ltd, Medical Resources International Pte Ltd, PCH Holding Pte. Ltd., GHK Hospital Limited, Parkway Healthcare (Hong Kong) Limited, Parkway HK Holdings Limited, Gleneagles JPMC Sdn Bhd, Shanghai Rui Pu Clinic Co., Ltd., Shanghai Hui Xing Jin Pu Clinic Co., Ltd, Shanghai Hui Xing Hospital Investment Management Co., Ltd, Shanghai Rui Xiang Clinic Co., Ltd., Shanghai Gleneagles Hospital Management Co Ltd, Parkway (Shanghai) Hospital Management Ltd, Suzhou Industrial Park Yuan Hui Clinic Co., Ltd, Shanghai Gleneagles International Medical Surgical Center, Suzhou Xin Hui Clinic Co., Ltd, ParkwayHealth Shanghai International Hospital Company Limited, Shanghai Xin Rui Healthcare Co., Ltd., Shanghai Rui Hong Clinic Co., Ltd., Shanghai Rui Xin Healthcare Co., Ltd., Shanghai Shukang Hospital Investment Management Co., Ltd, Shanghai Maikang Hospital Investment Management Co., Ltd, P T Tritunggal Sentra Utama
Present
Pacific Motor Sdn. Bhd., Metro Otomobil Sdn. Bhd.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Not Applicable
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not Applicable